These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21507808)

  • 1. Part D resources for pharmacists.
    Armor BL
    J Pharm Pract; 2010 Apr; 23(2):144-5. PubMed ID: 21507808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
    Alston G; Hanrahan C
    Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the impact of Part D on nursing home residents.
    Hudson N
    Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of Medicare Part D for community pharmacies.
    Stone D
    J Manag Care Pharm; 2009 Mar; 15(2):171-2. PubMed ID: 19236134
    [No Abstract]   [Full Text] [Related]  

  • 7. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
    Stubbings J; DePue RJ
    Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part D means health plans will have to pay pharmacists.
    Sipkoff M
    Manag Care; 2006 May; 15(5):14-5. PubMed ID: 16749515
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain.
    Urmie JM; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):85-9. PubMed ID: 20511107
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 17. Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor.
    Stuart B; Hendrick FB; Shen X; Dai M; Tom SE; Dougherty JS; Miller LM
    Health Aff (Millwood); 2016 Sep; 35(9):1572-80. PubMed ID: 27605635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839
    [No Abstract]   [Full Text] [Related]  

  • 19. The Part D shuffle. UnitedHealth, Humana lose business.
    Vesely R
    Mod Healthc; 2007 Oct; 37(40):17. PubMed ID: 18018374
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of drug consumption patterns for Medicare Part D patients.
    Pedan A; Lu J; Varasteh LT
    Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.